Overview

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Primary objectives: - To determine non-inferiority of FITpatch with regard to efficacy compared to standard opioid treatment - To assess the safety of FITpatch compared to standard opioid treatment Secondary objectives: - To assess the intake of oral morphine as rescue analgesic to FITpatch compared to standard opioid treatment - To assess Quality of life reported with FITpatch compared to standard opioid treatment
Phase:
Phase 3
Details
Lead Sponsor:
Nycomed
Treatments:
Fentanyl